GlassScriptPhysician profile
Troy R Norred
NPI 1780689844
$5,132.70
in general payments reported to CMS, 2019-2025
17 companies · $555 in 2025
The $555 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $811 · 2020: $497 · 2021: $1,875 · 2022: $278 · 2023: $578 · 2024: $539 · 2025: $555.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,672.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,671.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,466.32 | 2021-2022 | |
| Abbott Laboratories | $1,341.34 | 2020-2025 | Aveir, Gallant, Agilis Hispro |
| Medtronic Vascular, INC. | $920.07 | 2019-2020 | |
| Boston Scientific Corporation | $247.82 | 2022-2025 | Cds Broad Portfolio Offering |
| Shockwave Medical, INC | $247.24 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novartis Pharmaceuticals Corporation | $230.69 | 2019-2025 | |
| Irhythm Technologies, INC. | $199.68 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Regeneron Healthcare Solutions, INC. | $137.27 | 2019 | |
| Amgen INC. | $106.61 | 2021-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $75.09 | 2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.97 | 2024-2025 | Lifevest |
| Novo Nordisk INC | $29.33 | 2025 | Rybelsus, Ozempic |
| Philips North America LLC | $22.24 | 2025 | Extended Holter |
| Lantheus Medical Imaging, INC. | $18.69 | 2019 | |
| Bardy Diagnostics, INC. | $15.00 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.24 | 2019 | |
| Pfizer INC. | $14.10 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Troy Norred listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.